Human sCD44std Platinum ELISA

Description: The human sCD44std ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human sCD44std. The human sCD44std ELISA is for research use only. Not for diagnostic or therapeutic procedures.

CD44 is a cell membrane associated, polymorphic glycoprotein with apparent molecular weights ranging from 85 kDa to 250 kDa. CD44 isoforms participate in a wide variety of cell-cell or cell-matrix interactions including lymphocyte homing, establishment of B and T cell immune responses, tumor metastases formation and inflammation.

Three isoform categories of the CD44 molecule have been identified:
1) an 80-90 kDa isoform, the so-called standard form named CD44std, which is widely distributed on several hematopoietic and nonhemato-poietic cells including all subsets of leukocytes, monocytes, erythrocytes, many types of epithelium, mesenchymal elements like fibroblasts, smooth muscle cells and glial cells of the central nervous system,
2) a medium size category of 110-160 kDa which is weakly expressed on epithelial cells and highly expressed in some carcinomas and
3) a category which includes very large isoforms of 250 kDa covalently modified by the addition of chondroitin sulfate.

These bigger isoforms of CD44 arise by alternative splicing of one or more "variant" exons (v2-v10) into the extracellular part of the 90kDa constant form molecule. Compared to the standard CD44, all larger isoforms are expressed in a much more restricted fashion, only in a few normal tissues or on the surface of certain tumor cells. Some splice variants of CD44 play important and distinct roles in tumor metastasis.

Determination of sCD44std will provide more detailed insight into different pathological modifications during cancer and other diseases.

Citations: Fuchs,S.; Rolauffs,B.; Arndt,S.; Tibesku,C.O.; Prehm,P.. CD44H and the isoforms CD44v5 and CD44v6 in the synovial fluid of the osteoarthritic human knee joint. Osteoarthritis and Cartilage 2003;11:839-844. (Link)

Loeffler-Ragg,J.; Steurer,M.; Ulmer,H.; Skvortsov,S.; Kircher,B.; Herold,M.; Zwierzina,H.; Stauder,R.. Elevated levels of serum CD44 and E-cadherin predict an unfavourable outcome in myelodysplastic syndromes. Leukemia 2006;20:2064-2067. (Link)

Anderegg,Ulf; Eichenberg,Thea; Parthaune,Tanja; Haiduk,Christian; Saalbach,Anja; Milkova,Linda; Ludwig,Andreas; Grosche,Jens; Averbeck,Marco; Gebhardt,Carl; Voelcker,Verena; Sleeman,Jonathan; Simon,Jan. ADAM10 Is the Constitutive Functional Sheddase of CD44 in Human Melanoma Cells. J Invest Dermatol 2008;(Link)

Braumller,H.; Gansauge,S.; Ramadani,M.; Gansauge,F.. CD44v6 cell surface expression is a common feature of macrophages and macrophage-like cells - implication for a natural... FEBS Letters 2000;476:240-247. (Link)

Franzmann,Elizabeth J.; Reategui,Erika P.; Carraway,Kermit L.; Hamilton,Kara L.; Weed,Donald T.; Goodwin,W.Jarrard. Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer. Cancer Epidemiology Biomarkers & Prevention 2005;14:735-739. (Link)

Rouschop,K.; Roelofs,J.; Sylva,M.; Rowshani,A.; Berge,I.; Weening,J.; Florquin,S.. Renal expression of CD44 correlates with acute renal allograft rejection. Kidney Int 2006;70:1127-1134. (Link)

Niitsu N.,M Okamoto3,J Okabe-Kado2,T Takagi4,T Yoshida5,S Aoki6,Y Honma2 and M Hirano3. Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkins lymphoma. Leukemia 2001;15:832-839. (Link)

Rapti,M.; Atkinson,S.J.; Lee,M.H.; Trim,A.; Moss,M.; Murphy,G.. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition. Biochem.J 2008;411:433-439. (Link)

Niitsu,Nozomi; Okabe-Kado,Junko; Kasukabe,Takashi; Yamamoto-Yamaguchi,Yuri; Umeda,Masanori; Honma,Yoshio. Prognostic Implications of the Differentiation Inhibitory Factor nm23-H1 Protein in the Plasma of Aggressive Non-Hodgkin's Lymphoma. Blood 1999;94:3541-3550. (Link)

Krettek,Alexandra; Sukhova,Galina K.; Schonbeck,Uwe; Libby,Peter. Enhanced Expression of CD44 Variants in Human Atheroma and Abdominal Aortic Aneurysm: Possible Role for a Feedback Loop in Endothelial Cells. American Journal of Pathology 2004;165:1571-1581. (Link)

Prifti; Sillem; Arslic; Monga; Rehberger; Runnebaum. In vitro expression of soluble and cell surface-associated CD44 on endometrial cells from women with and without endometriosis. European Journal of Clinical Investigation 1998;28:1055-1060. (Link)

Sugahara,Kazuki N.; Murai,Toshiyuki; Nishinakamura,Hitomi; Kawashima,Hiroto; Saya,Hideyuki; Miyasaka,Masayuki. Hyaluronan Oligosaccharides Induce CD44 Cleavage and Promote Cell Migration in CD44-expressing Tumor Cells. Journal of Biological Chemistry 2003;278:32259-32265. (Link)

Niitsu,Nozomi; Okabe-Kado,Junko; Okamoto,Masataka; Takagi,Toshiyuki; Yoshida,Takashi; Aoki,Sadao; Hirano,Masami; Honma,Yoshio. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma. Blood 2001;97:1202-1210. (Link)

Kauppinen-Makelin,Ritva; Karma,Anni; Leinonen,Eeva; Loyttyniemi,Eliisa; Salonen,Oili; Sane,Timo; Setala,Kirsi; Viikari,Jorma; Heufelder,Armin; Valimaki,Matti. High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy. Acta Ophthalmologica Scandinavica 2002;80:316-321. (Link)

Franzmann,Elizabeth J.; Reategui,Erika P.; Pedroso,Felipe; Pernas,Francisco G.; Karakullukcu,Baris M.; Carraway,Kermit L.; Hamilton,Kara; Singal,Rakesh; Goodwin,W.Jarrard. Soluble CD44 Is a Potential Marker for the Early Detection of Head and Neck Cancer. Cancer Epidemiology Biomarkers & Prevention 2007;16:1348-1355. (Link)

Rouschop,Kasper M.A.; Roelofs,Joris J.T.H.; Rowshani,Ajda T.; Leemans,Jaklien C.; van der Poll,Tom; ten Berge,Ineke J.M.; Weening,Jan J.; Florquin,Sandrine. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection. Nephrology Dialysis Transplantation 2005;20:2248-2254. (Link)

Katoh,S.; Matsubara,Y.; Taniguchi,H.; Fukushima,K.; Mukae,H.; Kadota,J.; Matsukura,S.; Kohno,S.. Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis. Clinical and Experimental Immunology 2001;126:545-550. (Link)

Ma,Yue; Visser,Lydia; Roelofsen,Han; de Vries,Marcel; Diepstra,Arjan; van Imhoff,Gustaaf; van der Wal,Tineke; Luinge,Marjan; Alvarez-Llamas,Gloria; Vos,Hans; Poppema,Sibrand; Vonk,Roel; van den Berg,Anke. Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. Blood 2008;111:2339-2346. (Link)

Kaya,Grkan; Tran,Christian; Sorg,Olivier; Hotz,Raymonde; Grand,Denise; Carraux,Pierre; Didierjean,Liliane; Stamenkovic,Ivan; Saurat,Jean Hilaire. Hyaluronate Fragments Reverse Skin Atrophy by a CD44-Dependent Mechanism. PLoS Medicine 2006;3:(Link)

Masson,D.; Vusio,P.; Loirat,M.J.; Spring,F.; Anstee,D.J.; Denis,M.G.; Lustenberger,P.; Blanchard,D.. Epitope mapping of four novel CD44 monoclonal antibodies using surface plasmon resonance and soluble CD44. Transfusion Medicine 2001;11:447-454. (Link)

Komura,K.; Sato,S.; Fujimoto,M.; Hasegawa,M.; Takehara,K.. Elevated levels of circulating CD44 in patients with systemic sclerosis: association with a milder subset. Rheumatology 2002;41:1149-1154. (Link)

Hosono,Kozo; Nishida,Yoshihiro; Knudson,Warren; Knudson,Cheryl B.; Naruse,Takahiro; Suzuki,Yoshitaka; Ishiguro,Naoki. Hyaluronan Oligosaccharides Inhibit Tumorigenicity of Osteosarcoma Cell Lines MG-63 and LM-8 in Vitro and in Vivo via Perturbation of Hyaluronan-Rich Pericellular Matrix of the Cells. American Journal of Pathology 2007;171:274-286. (Link)

Dimitriadis,E.; Marwood,M.; Visser,K.; Salamonsen,L.A.. Interleukin 11 and leukaemia inhibitory factor regulate the adhesion of endometrial epithelial cells: implications in fertility regulation. Endocrinology 2009;en(Link)

Widney DP,Breen EC,Boscardin WJ,Kitchen SG,Alcantar JM,Smith JB,Zack JA,Detels R,Mart¡nez-Maza O.. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J Interferon Cytokine Res. 2005;25:702-706. (Link)

References: Humbria,A.; az-Gonzalez,F.; Campanero,M.R.; Arroyo,A.G.; Laffon,A.; Gonzalez-Amaro,R.; Sanchez-Madrid,F.. Expression of L-selectin, CD43, and CD44 in synovial fluid neutrophils from patients with inflammatory joint diseases. Evidence for a soluble form of L-selectin in synovial fluid. Arthritis Rheum. 1994;37:342-348. (Link)

Tolg,C.; Hofmann,M.; Herrlich,P.; Ponta,H.. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 1993;21:1225-1229. (Link)

Heider,K.H.; Dammrich,J.; Skroch-Angel,P.; Muller-Hermelink,H.K.; Vollmers,H.P.; Herrlich,P.; Ponta,H.. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res. 1993;53:4197-4203. (Link)

Fujiwara,K.; Yoshino,T.; Miyake,K.; Ohara,N.; Akagi,T.. Expression of a lymphocyte adhesion molecule (CD44) in malignant lymphomas: relevance to primary site, histological subtype and clinical stage. Acta Med.Okayama 1993;47:215-222. (Link)

Moller,P.; Eichelmann,A.; Mechtersheimer,G.; Koretz,K.. Expression of beta 1-integrins, H-CAM (CD44) and LECAM-1 in primary gastro-intestinal B-cell lymphomas as compared to the adhesion receptor profile of the gut-associated lymphoid system, tonsil and peripheral lymph node. Int J.Cancer 1991;49:846-855. (Link)

Salmi,M.; Gron-Virta,K.; Sointu,P.; Grenman,R.; Kalimo,H.; Jalkanen,S.. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J.Cell Biol. 1993;122:431-442. (Link)

Heider,K.H.; Hofmann,M.; Hors,E.; van den,Berg F.; Ponta,H.; Herrlich,P.; Pals,S.T.. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J.Cell Biol. 1993;120:227-233. (Link)

Kuppner,M.C.; Van,Meir E.; Gauthier,T.; Hamou,M.F.; de,Tribolet N.. Differential expression of the CD44 molecule in human brain tumours. Int.J.Cancer 1992;50:572-577. (Link)

Joensuu,H.; Ristamaki,R.; Klemi,P.J.; Jalkanen,S.. Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Br.J.Cancer 1993;68:428-432. (Link)

Koopman,G.; Heider,K.H.; Horst,E.; Adolf,G.R.; van den,Berg F.; Ponta,H.; Herrlich,P.; Pals,S.T.. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J.Exp.Med. 1993;177:897-904. (Link)

Matsumura,Y.; Tarin,D.. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992;340:1053-1058. (Link)

Guo,M.M.; Hildreth,J.E.. HIV-induced loss of CD44 expression in monocytic cell lines. J.Immunol. 1993;151:2225-2236. (Link)

Omary,M.B.; Trowbridge,I.S.; Letarte,M.; Kagnoff,M.F.; Isacke,C.M.. Structural heterogeneity of human Pgp-1 and its relationship with p85. Immunogenetics 1988;27:460-464. (Link)

Stamenkovic,I.; Amiot,M.; Pesando,J.M.; Seed,B.. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989;56:1057-1062. (Link)